skip to Main Content
Cannabis Investments Nearly Quadrupled in 2018

This year has been a turning point in the maturing marijuana market.

Cannabis-related companies raised nearly $13.8 billion so far this year, compared to just $3.5 billion in 2017, according to data from Viridian Capital Advisors, a financial and strategic advisory firm for the cannabis industry.

The spike in capital flowing into marijuana businesses in the last 12 months was driven by legislative changes both at the national level in Canada and at the state level in U.S. states like Michigan, Oklahoma and Utah. As public support for legalization grows, and growing public support for legalization—shifts that have given investors more confidence about backing companies in the space and enticed big players in the beverage and tobacco industries to make bets on cannabis products.

This year has been a turning point in the maturing marijuana market.

Cannabis-related companies raised nearly $13.8 billion so far this year, compared to just $3.5 billion in 2017, according to data from Viridian Capital Advisors, a financial and strategic advisory firm for the cannabis industry.

The spike in capital flowing into marijuana businesses in the last 12 months was driven by legislative changes both at the national level in Canada and at the state level in U.S. states like Michigan, Oklahoma and Utah.  [Read More @ Fortune]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

POSaBIT Buys Suite of Platforms (Leaf Data Systems, MJ Platform and Ample Organics) from Embattled Akerna Corp.

POSaBIT, the cannabis point-of-sale (POS) and payments software company, this morning announced its planned acquisition of  MJ Platform (MJ Freeway), Leaf Data Systems, and Ample Organics from embattled software company…

New York State now has 66 licensed cannabis retailers

New York marijuana regulators on Wednesday approved dozens of conditional adult-use dispensary licenses in a session during which members also discussed adopting bylaws for how the board runs meetings and makes decisions.…

FDA Says “No” to CBD Foods and Dietary Supplements

By Griffin Thorne, Attorney at Harris Bricken Since the passage of the 2018 Farm Bill, the hemp CBD industry has been eagerly awaiting FDA CBD regulations. In that time, FDA…

FDA finalizes guidance on cannabis clinical research

The US Food and Drug Administration has finalized a 2020 draft guidance outlining how sponsors and investigators can conduct clinical trials for certain drugs containing cannabis or cannabis-derived compounds without…

More Categories

Back To Top
×Close search
Search